A Bayesian adaptive design for estimating the maximum tolerated dose curve using drug combinations in cancer phase I clinical trials (Q7002163)
From MaRDI portal
!
This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use the normal view instead:
scientific article; zbMATH DE number 8022562
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | A Bayesian adaptive design for estimating the maximum tolerated dose curve using drug combinations in cancer phase I clinical trials |
scientific article; zbMATH DE number 8022562 |
Statements
A Bayesian adaptive design for estimating the maximum tolerated dose curve using drug combinations in cancer phase I clinical trials (English)
0 references
4 April 2025
0 references
cancer phase I trials
0 references
maximum tolerated dose curve
0 references
escalation with overdose control
0 references
drug combination
0 references
dose limiting toxicity
0 references
continuous dose
0 references
discrete dose
0 references
0 references
0 references
0 references
0 references
